Alterity Therapeutics (ATHE) Loans - Adjustments (2012 - 2013)
Alterity Therapeutics (ATHE) posted quarterly Loans - Adjustments of $37063.5 for Q4 2013, up 4.17% year-over-year from $35580.6 in Q4 2012, and up 11.93% quarter-over-quarter from $33113.4 in Q2 2013.
Alterity Therapeutics (ATHE) Loans - Adjustments (2012 - 2013) Analysis & Trends
Alterity Therapeutics' Loans - Adjustments history runs 2 years deep, the most recent figure standing at $37063.5 for Q4 2013.
- In Q4 2013, Loans - Adjustments rose 4.17% year-over-year to $37063.5; the TTM figure through Dec 2013 stood at $37063.5 (up 4.17% YoY), while the FY2013 annual figure was $33113.4, down 36.88% from the prior year.
- Loans - Adjustments for Q4 2013 stood at $37063.5, up from $33113.4 in the prior quarter.
- The five-year high for Loans - Adjustments was $51366.4 in Q2 2012, with the low at $33113.4 in Q2 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.47 Bn | 131.61 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.36 Bn | 78.37 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.16 Bn | 59.98 Bn | 1.37 Bn |
| 4 | Moderna | 58.99 Bn | 53.85 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.08 Bn | 36.98 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.74 Bn | 28.43 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.01 Bn | 9.61 Bn | 668.28 Mn |
| 8 | Insmed | 27.50 Bn | 26.34 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.28 Bn | 26.45 Bn | - |
| 10 | Alterity Therapeutics | 49.04 Mn | 16.74 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2013 | 37,063.54 |
| Jun 30, 2013 | 33,113.35 |
| Dec 31, 2012 | 35,580.59 |
| Jun 30, 2012 | 51,366.44 |